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   SIMULTANEOUS DETERMINATION OF 
CHLORPHENIRAMINE MALEATE, 
PHENYLEPHRINE HYDROCHLORIDE, 
PARACETAMOL AND CAFFEINE IN 
PHARMACEUTICAL PREPARATION BY 
RP-HPLC 
A reversed-phase High-Performance Liquid-Chromatography (RP-HPLC) me-
thod was successfully developed for the simultaneous determination of quater-
nary mixture consisting of chlorpheniramine maleate (CPM), phenylephrine 
hydrochloride (PE), paracetamol (PCM) and caffeine in pharmaceutical prepa-
ration. The method was found to be simple, sensitive and rapid. The sepa-
ration of the drugs was carried out using an Inertsil ODS C18 column using 
0.05M dibasic phosphate buffer: acetonitrile (93: 07; v/v) as the mobile phase. 
The flow rate of the mobile phase was adjusted to 1.5 ml/min and the column 
oven temperature was kept at 30 °C. All the drugs were resolved successfully 
with retention times 2.74 (CPM), 3.48 (PE), 9.5 (PCM) and 26.32 (caffeine) min 
when detection was carried out at 215 nm. The correlation coefficient was 
found to be 0.999, 0.998, 0.999 and 0.999, respectively for CPM, PE, PCM and 
caffeine. The relative standard deviation in the tablets was found to be less 
than 2% for six replicates. The method was validated for precision and accu-
racy. Thus, the proposed method can be successfully applicable to the phar-
maceutical preparation containing the above mentioned drugs without any 
interference of excipients. 
Keywords: chlorpheniramine maleate, phenylephrine hydrochloride, 
paracetamol, caffeine, RP-HPLC. 
 
 
Chlorpheniramine maleate (CPM), 3-(p-chloro-
phenyl)-3-(2-pyridyl)-N,N-dimethyl propylamine 
(C16H19ClN2, C4H4O4), is a powerful first-generation 
alkyl amine antihistamine, H1-receptor antagonist, 
widely used for symptomatic relief of common cold 
and allergic rhinitis, with weak sedative properties [1]. 
Phenylephrine hydrochloride  (PE),  (R)-1-(3-hydroxy-
phenyl)-2-methylaminoethanol hydrochloride 
(C9H13NO2, HCl) is useful as a nasal and sinus decon-
gestant [2]. Paracetamol (PCM),  acetaminophen, 4- 
-hydroxyacetanilide (C8H9NO2), is a popular over-the-
counter non-opiate, non-salicylate, analgesic and 
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antipyretic drug. Addition of PCM to NSAID is well 
tolerated and effective in the treatment of osteoar-
thritis flare pain because of synergistic analgesic ef-
fect [3]. Caffeine, 3,7-dihydro-1,3,7-trimethyl-1H-pu-
rine-2,6-dione (C8H10N4O2), is ranked as the number 
one drug worldwide and is usually employed as cen-
tral nervous system stimulant. Along with PCM, its 
effectiveness as an analgesic and antipyretic in phar-
maceutical formulation is well established [4]. 
High Performance Liquid Chromatography (HPLC) 
has been highly used in the quality control of drugs 
because of its sensitivity, reproducibility and speci-
ficity. Even though HPLC is the method of choice for 
analysis of multi-component pharmaceutical prepara-
tion, it requires a separation treatment and several 
injections during analysis. In chromatographic anal-
ysis, the main problem of this method involves the 
optimization of experimental conditions such as se-V.K. REDASANI et al.: SIMULTANEOUS DETERMINATION OF CHLORPHENIRAMINE MALEATE…  CI&CEQ 19 (1) 57−65 (2013) 
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lection of column type, temperature of the column, 
variety and composition of the mobile phase, selec-
tion of specific wavelength and cheap instrumentta-
tion. In spite of the fact that this method undoubtedly 
provides more sensitive determination than the spec-
trophotometric methods, Reversed Phase Chroma-
tography (RPC) is effective, reproducible and rugged 
and often easier for UV detectors. It has now become 
the method of choice for most of drug and combi-
nations of drugs [5,6]. 
Literature survey shows that several HPLC me-
thods have been reported for PCM and its combi-
nations in pharmaceuticals or in biological fluids. Most 
of them are used for the determination of binary com-
binations like PCM–CPM [7,8] or ternary combinations 
like PCM-caffeine-codeine [9], PCM-caffeine-propyl-
phenazone [10], PCM–caffeine–CPM [11] and PCM-
aspirin-caffeine [12]. Various methods have been re-
ported for estimation of CPM and PE combinations in 
pharmaceuticals by HPLC [13-21].
  Few HPLC me-
thods have been reported for the estimation of caf-
feine in combination like PCM, caffeine and dipyrone 
[22]. 
Several spectrophotometric methods have also 
been reported for the estimation of CPM and PE 
combinations [2,13,23]. Capillary electrophoresis me-
thods have been reported for the estimation of PCM, 
CPM and PE combination [21], methods for deter-
mination of  PCM, caffeine, pseudoephedrine, CPM 
and cloperastine in human plasma by LC-MS [24] and
 
H-point standard addition method for the estimation of 
PCM and caffeine [25] have been reported. 
Motivated by the aforementioned findings, it was 
thought to estimate quaternary mixture of PCM, CPM, 
PE and caffeine by RP-HPLC as no RP–HPLC me-
thod is reported for combination of all these four 
drugs. Since these drugs in combination are accepted 
widely in respiratory tract infections, there is need to 
develop and validate analytical methods for their 
determination in dosage form. Thus, an attempt has 
made to develop and validate HPLC method for the 
estimation of PCM, CPM, PE and caffeine from the 
tablet formulation. 
EXPERIMENTAL 
Materials and reagents  
CPM, PE, PCM and caffeine  were kindly sup-
plied by Plethico Pharmaceuticals Ltd. (India). Aceto-
nitrile (HPLC grade) was obtained from Rankem, 
India. Methanol (HPLC grade) and potassium dihyd-
rogen phosphate (A. R. grade) were obtained from 
Merck Mumbai, India, and used as obtained. Water 
was deionised and double distilled. Pharmaceutical 
dosage form containing CPM, PE, PCM and caffeine 
was obtained commercially. Each tablet was labelled 
to contain 4 mg CPM, 5 mg PE, 500 mg PCM and 30 
mg caffeine.  
Equipment and chromatographic conditions 
The HPLC consisted of a degasser DGU-20 A5, 
pump LC-20 AT, oven CTO-10 ASVP, SPD M-20A 
photo diode array detector and a SIL-M 20AC pro-
minence auto sampler with data processor LC solu-
tion (Shimadzu, Japan). All pH measurements were 
performed on a µ pH System 362 (Systronics, India). 
Chromatographic separation was carried isocratically 
at room temperature with an Inertsil ODS C18 (250 
mm×4mm i.d., 5 μm) column from G. L. Sciences Inc., 
Japan. Mobile phase was prepared by dissolving 6.8 
g of potassium dihydrogen phosphate in 1000 ml of 
double-distilled water. The buffer solution was soni-
cated for 10 min and finally the volume was fulfilled 
up to 1000 ml with the same solvent. The pH of the 
dibasic phosphate buffer was adjusted to 4.0 with 
ortho-phosphoric acid. A mixture of 0.05 M dibasic 
phosphate buffer and acetonitrile in the ratio of 93:07 
was prepared. Finally, the mobile phase was filtered 
through a 0.45 μm membrane filter and degassed for 
10 minutes. The injection volumes for samples and 
standards were 20 μl and eluted at a flow rate of 1.5 
ml/min at 30 °C. The eluents were monitored at 215 nm. 
Preparation of standard solutions 
A working standard solution containing CPM 4 
μg/ml, PE 5 μg/ml, PCM 500 μg/ml and caffeine 30 
μg/ml was prepared by dissolving CPM, PE, PCM and 
caffeine reference standard in diluents (acetonit-
rile:buffer, 50:50v/v). The mixture was sonicated for 
15 min or until the reference standard dissolved com-
pletely. 
Preparation of sample solutions 
Twenty tablets, each containing 4 mg CPM, 5 
mg PE, 500 mg PCM and 30 mg caffeine are weighed 
accurately and powdered finely. A quantity of powder 
which is equivalent to 4 mg of CPM, 5 mg of PE, 500 
mg of PCM and 30 mg of caffeine was weighed ac-
curately and transferred into a 200 ml calibrated volu-
metric flask. About 50 ml of diluent was added and 
ultrasonicated for 15 min; finally the volume was ad-
justed to the mark. The resulting solution obtained 
was then filtered, through 0.45 µm filter for complete 
removal of particulate matter. 5 ml of the filtrate was 
diluted to 25 ml in the volumetric flask with the diluent 
for analysis. V.K. REDASANI et al.: SIMULTANEOUS DETERMINATION OF CHLORPHENIRAMINE MALEATE…  CI&CEQ 19 (1) 57−65 (2013) 
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Method validation 
The proposed method was subjected to valida-
tion for various parameters like system suitability, 
specificity, range and linearity, accuracy, precision 
and robustness in accordance with International Con-
ference on Harmonization guidelines [26]. The repli-
cates of drugs (50 μg/ml) were carried out to assess 
the system suitability. It was further evaluated by 
analyzing the repeatability, peaks symmetry (sym-
metry factor), theoretical plates of the column, reso-
lution between the peaks, tailing factor and relative 
retention time. The specificity of the chromatographic 
method was determined to ensure separation of 
CPM, PE, PCM and caffeine. Specificity was also 
determined in the presence of excipients used in 
formulation, CPM, PE, PCM and caffeine was spiked 
(at a concentration of 4 μg/ml CPM, 5 μg/ml PE, 500 
μg/ml PCM and 30 μg/ml caffeine) in placebo and 
chromatogram was observed and compared with that 
of reference standard. A PDA detector was used to 
check the peak purity. 
The linearity is important to demonstrate that the 
response of the measurement of detector system is 
linear over the range of interest of the method. This 
was determined by means of calibration graph using 
increasing amounts of a standard solution (80, 90, 
100, 110 and 120%) of all four drugs. Six replicates of 
the standard were tested according to ICH guidelines. 
A calibration curve was constructed and the proposed 
method was evaluated by its correlation coefficient 
and intercept value (ANOVA, p < 0.05). The correla-
tion co-efficient was found within limit. 
The method was validated for accuracy and pre-
cision. The accuracy of the method was studied as 
mean % recovery. Accuracy was determined by means 
of recovery experiments, by spiked addition of active 
drug to placebo formulations. It was shown that the 
recoveries were independent of the concentration of 
the active drug over a reasonable concentration 
range normally 80 to 120% of the nominal concentra-
tion. The accuracy of the assay was measured by 
analyzing samples of CPM, PE, PCM and caffeine, by 
spiking known amounts of said drugs in the placebo, 
at different concentration levels (viz. 80, 100 and 120%). 
ICH guidelines recommend that precision must 
be considered at two levels, i.e., repeatability and 
intermediate precision. The repeatability of the me-
thod was tested by injecting 100% concentration of 
four analytes of the regular analytical working value 
consecutively for six times and examining the effects 
on the results. The intermediate precision was tested 
with respect to laboratory variations, i.e., by using 
different equipments, different analysts and days. The 
relative standard deviation (%RSD) was determined 
to assess the precision of the assay and it was not 
more than 2.0%.  
Robustness studies were done by making slight 
variations in flow rate, amount of acetonitrile, and 
detection wavelength changes once at a time. 
The sensitivity of the proposed method was 
estimated in terms of limit of detection (LOD) and limit 
of quantitation (LOQ); LOD = 3.3SD/S and LOQ = 
= 10SD/S, where SD is the residual standard devi-
ation and S is the slope of the line. For the LOD and 
LOQ study, concentrations between first and second 
were selected. The concentrations between 3.2-3.6, 4 
-4.4, 400-450, 24-27 µg/ml were prepared of CPM, 
PE, PCM and caffeine respectively. 
RESULTS AND DISCUSSION 
Quality control of drugs or drug products is of 
prime importance. HPLC methods are used routinely 
for the quantitation of drug substances. The goal of 
this study was to develop a rapid, sensitive, accurate, 
precise and reliable HPLC method for the analysis of 
CPM, PE, PCM and caffeine from tablets formulations 
using the most commonly employed C18 column with 
PDA detector.  
Methods development and optimization 
This isocratic-mode method with PDA detection 
was developed for the determination of the active 
ingredients, CPM, PE, PCM and caffeine at 100% 
level. Firstly, the reversed-phase column was tested. 
The column gives very efficient and reproducible se-
paration of the components while minimizing solvent 
usage. Consequently, it was selected for the method 
development. The system suitability studies were car-
ried out as specified in ICH guidelines.  
The mobile phase consisted of dibasic phos-
phate buffer solution and acetonitrile at various ratios 
(80:20, 85:15, 90:10 and 93:07, v/v) was tested as 
starting solvent. The variation in the mobile phase 
leads to considerable changes in the chromategra-
phic parameters. However, the proportion buffer: ace-
tonitrile at a ratio of 93:07 (v/v) yielded the best results.  
For studying the effect of excipients on quanti-
fication of CPM, PE, PCM and caffeine, a placebo 
was analysed. The result obtained indicates that ex-
cipients have no interference. Based on the highest 
UV absorbance for CPM, PE, PCM and caffeine, 215 
nm was chosen for detection of this new HPLC me-
thod at which the best detector responses for all sub-
stances were obtained. The overlaid UV spectrum is 
shown in Figure 1. V.K. REDASANI et al.: SIMULTANEOUS DETERMINATION OF CHLORPHENIRAMINE MALEATE…  CI&CEQ 19 (1) 57−65 (2013) 
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Method validation 
System suitability testing 
The results obtained for system suitability are 
summarized in Table 1 and the values are found 
within the limits. System suitability test are an integral 
part of chromatographic methods and are used to 
verify that the resolution and reproducibility of the sys-
tem are adequate for the analysis to be performed.  
Range and linearity  
The range of an analytical method is the interval 
between analytical concentration for upper and lower 
limit of a sample where the method has shown to 
demonstrate acceptable accuracy, precision and line-
arity. The linearity of the method was observed in the 
expected concentration range demonstrating its suit-
ability for analysis. The calibration curves were cons-
tructed with five concentrations (Figure 2). The re-
gression statistics are shown in Table 2. The good-
ness-of-fit (r
2) was found to be > 0.999 and value of 
intercept was less than 2% of the response of 100% 
concentration in all the cases indicating functional li-
near relationship between the concentration of anal-
yte and area under the peak. 
Accuracy 
The accuracy was evaluated by the recovery of 
CPM, PE, PCM and caffeine at three different levels 
(80, 100 and 120%). The results of accuracy studies 
are shown in Table 3. Recoveries of CPM, PE, PCM 
and caffeine were 99.38-101.48%, 100.29-101.68%, 
100.65-101.29% and 98.74-100.25%, respectively, with 
coefficients of variation ranging from 0.10%-0.29%, 
0.34%-0.85%, 0.21%-0.24% and 0.09%-0.13%, res-
pectively. Therefore, it is evident that the method is 
accurate within the desired range.  
Precision 
The precision of this method was determined by 
intra-day and inter-day precision. It was expressed as 
%RSD of a series of measurement. The experimental 
values obtained for the repeatability of CPM, PE, 
PCM and caffeine in samples are presented in Table 
4. The obtained results show %RSD < 2, indicating 
good intra-day precision. Inter-day variability was also 
calculated by performing the assay on two days, and 
the mean %RSD was < 2 (Table 5). All the data ob-
tained were within the acceptance criteria. 
 
Figure 1. Overlaid UV spectra of CPM (1), PE (2), PCM (3) and caffeine (4). 
Table 1. System suitability parameters 
Parameter Chlorpheniramine  Phenylephrine  Paracetamol  Caffeine 
Theoretical plates (N) 2474  6351  11966  15141 
Resolution (Rs) 7.9  5.6  23.2  28.0 
Tailing factor (T) 1.31  1.23  1.12  1.03 
Retention time (Rt /  min) 2.74 3.48  9.5 26.32 V.K. REDASANI et al.: SIMULTANEOUS DETERMINATION OF CHLORPHENIRAMINE MALEATE…  CI&CEQ 19 (1) 57−65 (2013) 
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Figure 2. Calibration curves for CPM, PE, PCM and caffeine showing linearity. 
Table 2. Linearity study data 
Parameter CPM  PE  PCM  Caffeine 
Linearity range, µg/ml  3.2-4.8  4-6  400-600  24-36 
Regression equation  y = 1061.8x - 84.76  y = 1219.9x + 1562.3 y = 131327x + 206.1  y = 18178x + 2796.6 
Correlation coefficient (r
2) 0.999  0.998  0.999  0.999 
Table 3. Recovery study data; SD – standard deviation; RSD – the relative standard deviation 
Drugs  Amount added, %  Amount added, mg  Amount recovery, mg  Amount recovery±SD, %  Mean recovery, %  %RSD
CPM 80  3.3  3.35  101.48±0.30  100.43  0.29 
100 4.2  4.17  99.38±0.20  0.20 
120 4.7  4.72  100.45±0.10  0.10 
PE 80  3.8  3.86  101.68±0.86  101.29  0.85 
100 5.3  5.40  101.91±0.89  0.87 
120 5.9  5.92  100.29±0.34  0.34 
PCM 80  403.5  405.17  100.66±0.24  100.87  0.24 
100 509.1  512.4  100.65±0.21  0.21 
120 610.1  618.09  101.29±0.21  0.21 
Caffeine 80  23.5  23.08  98.74±0.13  99.48  0.13 
100 30.1  30.17  100.25±0.22  0.22 
120 36.4  36.20  99.45±0.09  0.09 V.K. REDASANI et al.: SIMULTANEOUS DETERMINATION OF CHLORPHENIRAMINE MALEATE…  CI&CEQ 19 (1) 57−65 (2013) 
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Table 4. Repeatability; SD – standard deviation; RSD – the relative standard deviation 
Drug Mean  area
a±SD %RSD 
Chlorpheniramine 102845±246  0.24 
Phenylephrine 120491±163  0.14 
Paracetamol 12607302±9251  0.07 
Caffeine 1812047±813  0.04 
aAverage of six determinations 
Table 5. Intermediate precision 
Inter-day 
Sample  Day 1  Day 2 
Drugs  Mean Area±SD  % RSD  Mean Area±SD  % RSD 
CPM 103071±166  0.16  102834±249  0.24 
PE 120501±314  0.26  119532±508  0.43 
PCM 12579873±30798  0.24  12621530±49616  0.39 
Caffeine 1813174±2037  0.11  1809529±2138  0.12 
Different Instruments 
Sample  Instrument 1  Instrument 2 
Drugs  Mean Area±SD  % RSD  Mean Area±SD  % RSD 
CPM 103071±166  0.16  103034±437  0.42 
PE 120501±314  0.26  120518±555  0.46 
PCM 12579873±30798  0.24  12622959±25363  0.20 
Caffeine 1813174±2037  0.11  1813367±1953  0.11 
Different Analysts 
Sample  Analyst 1  Analyst 2 
Drugs  Mean Area±SD  % RSD  Mean Area±SD  % RSD 
CPM 103071±166  0.16  102895±112  0.11 
PE 120501±314  0.26  120386±504  0.42 
PCM 12579873±30798  0.24  12590144±20324  0.16 
Caffeine 1813174±2037  0.11  1810949±4450  0.25 
 
Specificity 
For determining the specificity of the method for 
drug formulation, the drug was spiked, wherein the 
excipients used in different formulation products did 
not interfere with the drug peak and thus the method 
was found to be specific for CPM, PE, PCM and 
caffeine (Figure 3). The present method demons-
trates good resolution between the peaks and was 
found to be free of interference.  
Robustness of method 
To evaluate robustness, various parameters were 
deliberately varied. The parameters Include variation 
of flow rate, percentage of ACN, detection wave-
length, column etc. using 4, 5, 500 and 30 mg of CPM, 
PE, PCM and caffeine, respectively. Results are shown 
in Table 6. 
Sensitivity 
The sensitivity of method is described in terms 
of LOD and LOQ. The LOD were 0.29, 0.41, 38, 2.4 
and LOQ were 0.4, 0.51, 49, and 3.3 for CPM, PE, 
PCM and caffeine, respectively. 
Label claim recoveries from tablets 
The proposed method was evaluated in the 
assay of commercially available tablets containing 
CPM (4 mg), PE (5 mg), PCM (500 mg) and caffeine 
(30 mg). Six replicate determinations (n = 6) were 
carried out on an accurately weighted amount of the 
pulverized tablets equivalent to 4 mg of CPM, 5 mg of 
PE, 500 mg of PCM and 30 mg of caffeine. The label 
claim found is shown in Table 7. The chromatogram 
of the sample is shown in Figure 4. 
CONCLUSION  
A reversed-phase HPLC method was developed 
and validated for the simultaneous determination of 
CPM, PE, PCM and caffeine and proved to be more 
convenient and effective for the quality control of 
these drugs in pharmaceutical dosage forms. The me-V.K. REDASANI et al.: SIMULTANEOUS DETERMINATION OF CHLORPHENIRAMINE MALEATE…  CI&CEQ 19 (1) 57−65 (2013) 
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Figure 3. Chromatogram of placebo solution showing no interference. 
Table 6. Robustness of method 
Parameter  Variation  CPM (RT)  PE (RT)  PCM (RT)  Caffeine (RT) 
Flow rate  1.4  2.94  3.70  10.17  28.08 
1.6 5.56 3.21  8.77 23.90 
Mobile Phase 
Composition 
92:8 2.67  3.16  8.15  19.85 
94:6 2.82  3.28  11.07 34.53 
Wavelength 210  2.74  3.46  9.5  26.35 
220 2.74 3.46 9.5  26.35 
Table 7. Assay of tablet formulation; SD – standard deviation 
Component  Labeled amount, mg  Amount found, mean
a±SD, mg  Amount found, mean±SD, % 
Chlorpheniramine 4  4.02±0.01  100.51±0.24 
Phenylephrine 5  4.99±0.01  99.87±0.14 
Paracetamol 500  508.37±0.37  101.67±0.075 
Caffeine 30  29.82±0.02  99.39±0.05 
aAverage of six determinations 
 
Figure 4. Typical chromatogram of sample. V.K. REDASANI et al.: SIMULTANEOUS DETERMINATION OF CHLORPHENIRAMINE MALEATE…  CI&CEQ 19 (1) 57−65 (2013) 
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thod is found to be simple, precise, accurate, specific, 
selective and linear over the concentration range 
tested (80–120%) with a correlation coefficient better 
than 0.9991. The good percentage recovery in tablet 
dosage forms suggests that the excipients present in 
the dosage forms have no interference in the deter-
mination. The percent RSD was also less than 2% 
showing high degree of precision of the proposed me-
thod. So, the method is suitable for the determination 
of the drugs in tablets without interference from com-
monly used excipients, and could be used in a quality 
control laboratory for routine sample analysis. 
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NAUČNI RAD 
   SIMULTANO ODREĐIVANJE HLORFENIRAMIN 
MALEATA, FENILEFRIN HIDROHLORIDA, 
PARACETAMOLA I KAFEINA U FARMACEUTSKIM 
PREPARATIMA RP-HPLC METODOM 
RP-HPLC metoda je uspešno primenjena za određivanje hlorfeniramin maleata (CPM), 
fenilefrin hidrohlorida (PE), paracetamola (PCM) i kafeina u kvaternernoj smeši u farma-
ceutskim preparatima. Nađena metoda je brza, jednostavna i osetljiva. Razdvajanje ispi-
tivanih jedinjenja je izvedeno na koloni Inertsil ODS C18 uz upotrebu mobilne faze fos-
fatni puffer:acetonitril (93:7; v/v). Protok mobilne faze je podešen na 1,5 ml/min, a tem-
peratura kolone je održavana na 30 °C. Sva ispitivana jedinjenja su uspešno razdvo-
jena, komponente su detektovane na 215 nm, a njihova retenciona vremena su sledeća: 
2.74 (CPM), 3.48 (PE), 9.5 (PCM) i 26.32 (kafein) min. Korelacioni koeficijenti određiva-
nja su 0,999 za CPM, 0,998 za PE, 0,999 za PCM i 0,999 za koefin. Relativna stan-
dardna devijacija za odeređivanja u tabletama je manja od 2 % za šest ponavljanja. Me-
toda je validirana za preciznost i tačnost. Predložena metoda se uspešno može prime-
niti za određivanje ispitivanih lekova u farmaceutskim preparatima bez interferencije po-
moćnih supstanci. 
Ključne reči: hlorfeniramin maleat, fenilefrin hidrohlorid, paracetamol, kafein, 
RP-HPLC. 
 
 